Limited Edition Golden Llama is here! Check out how you can get one. Limited Edition Golden Llama is here! Check out how you can get one.
Offering SPR-BLI Services - Proteins provided for free! Get your ComboX free sample to test now!
Time Limited Offer: Welcome Gift for New Customers ! Shipping Price Reduction for EU Regions
Cat . Non | Espèces | Description du produit | Structure | Pureté | Caractéristique |
---|---|---|---|---|---|
AHE-H52H3 | Human | Human ACHE / Acetylcholinesterase Protein, His Tag (active enzyme) |
|
Name | Research Code | Research Phase | Company | First Brand Name | First Approved Country | First Indication | First Approved Company | First Approved Date | Indications | Clinical Trials |
---|---|---|---|---|---|---|---|---|---|---|
Galantamine Hydrobromide | GP-37267; R-113675 | Approved | AverTox, Nivalin, Reminyl, Razadyne, Reminyl XL | Mainland China | Alzheimer Disease | null | 1981-01-01 | Dementia; Mental Disorders; Fasting; Subarachnoid Hemorrhage; Frontotemporal Dementia; Stress Disorders, Traumatic, Acute; Dementia, Vascular; Cognition Disorders; Cocaine-Related Disorders; Obesity; Nervous System Diseases; Lewy Body Disease; Schizophrenia; Alzheimer Disease; Cognitive Dysfunction; Tobacco Use Disorder; AIDS Dementia Complex; Vascular Diseases; Memory; Autistic Disorder; Stroke; Insulin Resistance; Brain Diseases | Details | |
Neostigmine Bromide | Approved | Prostigmin | Mainland China | Myasthenia Gravis; Flatulence; Urinary Retention | Shanghai Sine Pharmaceutical Laboratories Co Ltd | 1995-01-01 | Myasthenia Gravis; Headache; Flatulence; Urinary Retention | Details | ||
Metrifonate | Bay-a-9826; Bayer-L-1359 | Approved | ProMem, Memobay, Bilarcil | Schistosomiasis | Details | |||||
Rivastigmine Tartrate | SDZ-212-713; SDZ-ENA-713; LY-30410; LY-03011; ONO-2540; ENA-713; LY 03013; ENA-713D; LY30410 | Approved | Novartis Pharma Ag | Exelon TDS, Rivastach, Exelon MR, Prometax, Exelon, 艾斯能 | EU | Parkinson Disease; Dementia; Alzheimer Disease | Novartis Europharm Ltd | 1998-05-11 | Substance-Related Disorders; Down Syndrome; Brain Injuries, Traumatic; Delirium; Neurobehavioral Manifestations; Alzheimer Disease; Parkinson Disease; Dementia; Cocaine-Related Disorders; Dementia, Vascular; Cognition Disorders | Details |
Pyridostigmine Bromide | Ro-1-5130 | Approved | Valeant | Regonol, Mestinon | United States | Lambert-Eaton Myasthenic Syndrome | Bausch & Lomb (Singapore) Pvi Ltd | 1955-04-06 | Dyskinesias; HIV Seropositivity; Immunologic Deficiency Syndromes; Hypotension, Orthostatic; Fibromyalgia; Diabetes Mellitus; T-Lymphocytopenia, Idiopathic CD4-Positive; Fatigue Syndrome, Chronic; Parkinson Disease; Glycogen Storage Disease Type II; Constipation; Poisoning; Prostatic Neoplasms, Castration-Resistant; Coronavirus Disease 2019 (COVID-19); Postural Orthostatic Tachycardia Syndrome; Lambert-Eaton Myasthenic Syndrome; Heart Failure; Myasthenia Gravis; Primary Dysautonomias; HIV Infections | Details |
Dimebolin hydrochloride | BRN-0622478; PF-01913539; DMB-I | Approved | Bigespas Ltd | Dimebon | Russian Federation | Rhinitis, Allergic; Dermatitis, Atopic; Hypersensitivity | null | 1983-01-01 | Liver Failure; Huntington Disease; Rhinitis, Allergic; Alzheimer Disease; Dementia; Dermatitis, Atopic; Hypersensitivity | Details |
Donepezil Hydrochloride | DKF-310; BNAG; E-2020; E-2022; (±)-E-2020; IVL-3003; GB-5001; HZ007 | Approved | Eisai Co Ltd | Memac, Eranz, Memorit, Aricept Evess, Aricept, Aricept ODT, Aricept D, 安理申, ADLARITY | United States | Alzheimer Disease | Eisai Inc | 1996-11-25 | Cognitive Dysfunction; Autistic Disorder; Aphasia; Central Nervous System Neoplasms; Multiple Sclerosis; Breast Neoplasms; Fragile X Syndrome; Brain Neoplasms; Psychology; Alzheimer Disease; Alcoholism; Hearing Loss, Sensorineural; Dementia; Parkinson Disease; Lewy Body Disease; Wounds and Injuries; Memory Disorders; Dementia, Vascular; Neoplasm Metastasis; Cognition Disorders; Subarachnoid Hemorrhage; Autism Spectrum Disorder; Supranuclear Palsy, Progressive; Drug-Related Side Effects and Adverse Reactions; Migraine Disorders; Brain Ischemia; Diabetes Mellitus, Type 2; Depression; Down Syndrome; Osteoporosis; Neurologic Manifestations; Visual Perception; Neoplasms; Attention Deficit Disorder with Hyperactivity; Smoking Cessation; Delirium; Anxiety Disorders; Sleep Wake Disorders; Fatigue; Stroke; Radiation Injuries | Details |
Memantine Hydrochloride/Donepezil Hydrochloride | ADS-8704; D-797/D-324; CKD 355; BPS-034; BPDO-1603; MDX-8704 | Approved | Allergan Plc | Arimenda, Namzaric | United States | Alzheimer Disease | Abbvie Inc | 2014-12-23 | Alzheimer Disease | Details |
Huperzine A | SPN-817 | Approved | Chinese Academy Of Sciences, Mayo Clinic | 哈伯因, 双益平 | Mainland China | Alzheimer Disease | Henan Taloph Pharmaceutical Stock Co Ltd | 1994-01-01 | Schizophrenia; Brain Injuries, Traumatic; Seizures; Alzheimer Disease; Epilepsy; Learning Disabilities; Memory Disorders | Details |
Distigmine Bromide | BC-51 | Approved | Torii Pharmaceutical Co Ltd | Ubretid | Japan | Glaucoma; Cystitis; Myasthenia Gravis; Strabismus | Torii Pharmaceutical Co Ltd | 1967-09-05 | Myasthenia Gravis; Cystitis; Glaucoma; Strabismus | Details |
Pralidoxime Chloride | 2-PAM-chloride | Approved | Baxter International Inc | Protopam chloride | United States | Poisoning | Baxter Healthcare Corp | 1964-03-11 | Poisoning | Details |
Pralidoxime Iodide | 2-PAMI; NSC-7760; 2-PAM Iodide | Approved | Japan | Poisoning | Sumitomo Dainippon | 1958-05-01 | Poisoning | Details | ||
Eserine Salicylate | Approved | Synapton SR, Xalieve, Antilirium | Insulin Resistance; Pain, Postoperative; Psychotic Disorders; Glaucoma | Details | ||||||
Neostigmine methylsulfate | Approved | Bloxiverz, Intrastigmina, Juvastigmin, Stiglyn, Metastigmin | Japan | Myasthenia Gravis; Muscle Hypotonia | kyowayakuhin Co | 1936-10-01 | Myasthenia Gravis; Flatulence; Urinary Retention; Reversal of Neuromuscular Blockade; Muscle Hypotonia | Details | ||
Naphazoline Hydrochloride/Neostigmine methylsulfate/Glycyrrhizinate dipotassium/Chlorphenamine Maleate/Aspartic Acid/Vitamin B6 | Approved | 新乐敦 | Details | |||||||
Dextrose/Sodium Chloride/Potassium Chloride/Floxacillin sodium | Approved | Details | ||||||||
Dextrose/Sodium Chloride/Potassium Chloride/Anthralin | Approved | Details | ||||||||
Dextrose/Sodium Chloride/Potassium Chloride/Pralidoxime Chloride | Approved | Details | ||||||||
Pralidoxime Chloride/Benactyzine Hydrochloride/Atropine Sulfate | Approved | Poisoning | Details | |||||||
Naphazoline Hydrochloride/Neostigmine methylsulfate | Approved | Details | ||||||||
Dihydrogalanthamine Hydrobromide | Approved | Mainland China | Hemiplegia; Sciatica | null | 1982-01-01 | Hemiplegia; Sciatica | Details | |||
Securinine Nitrate | Approved | Poliomyelitis; Facial Paralysis | Details | |||||||
Rivastigmine | Approved | Novartis Pharma Ag | Parkinson Disease; Alzheimer Disease | Details | ||||||
Glycopyrronium bromide/Neostigmine metilsulfate | Approved | Sintetica Gmbh | Novistig | Sintetica Gmbh | 2020-07-29 | Drug Overdose; Reversal of Neuromuscular Blockade; Muscle Hypotonia; Neuromuscular Diseases | Details | |||
Atropine/Pralidoxime Chloride | Approved | Meridian Medical Technologies Inc | DUODOTE | United States | Poisoning; Organophosphate Poisoning | Meridian Medical Technologies LLC | 2002-01-17 | Drug-Related Side Effects and Adverse Reactions; Organophosphate Poisoning; Poisoning; Drug intoxications | Details | |
Acotiamide Hydrochloride Hydrate | Z-338; YM-443 | Approved | Zeria | Acofide | Japan | Dyspepsia | null | 2013-03-25 | Dyspepsia; Nausea | Details |
Galantamine Hydrobromide | GP-37267; R-113675 | Approved | AverTox, Nivalin, Reminyl, Razadyne, Reminyl XL | Mainland China | Alzheimer Disease | null | 1981-01-01 | Dementia; Mental Disorders; Fasting; Subarachnoid Hemorrhage; Frontotemporal Dementia; Stress Disorders, Traumatic, Acute; Dementia, Vascular; Cognition Disorders; Cocaine-Related Disorders; Obesity; Nervous System Diseases; Lewy Body Disease; Schizophrenia; Alzheimer Disease; Cognitive Dysfunction; Tobacco Use Disorder; AIDS Dementia Complex; Vascular Diseases; Memory; Autistic Disorder; Stroke; Insulin Resistance; Brain Diseases | Details | |
Neostigmine Bromide | Approved | Prostigmin | Mainland China | Myasthenia Gravis; Flatulence; Urinary Retention | Shanghai Sine Pharmaceutical Laboratories Co Ltd | 1995-01-01 | Myasthenia Gravis; Headache; Flatulence; Urinary Retention | Details | ||
Metrifonate | Bay-a-9826; Bayer-L-1359 | Approved | ProMem, Memobay, Bilarcil | Schistosomiasis | Details | |||||
Rivastigmine Tartrate | SDZ-212-713; SDZ-ENA-713; LY-30410; LY-03011; ONO-2540; ENA-713; LY 03013; ENA-713D; LY30410 | Approved | Novartis Pharma Ag | Exelon TDS, Rivastach, Exelon MR, Prometax, Exelon, 艾斯能 | EU | Parkinson Disease; Dementia; Alzheimer Disease | Novartis Europharm Ltd | 1998-05-11 | Substance-Related Disorders; Down Syndrome; Brain Injuries, Traumatic; Delirium; Neurobehavioral Manifestations; Alzheimer Disease; Parkinson Disease; Dementia; Cocaine-Related Disorders; Dementia, Vascular; Cognition Disorders | Details |
Pyridostigmine Bromide | Ro-1-5130 | Approved | Valeant | Regonol, Mestinon | United States | Lambert-Eaton Myasthenic Syndrome | Bausch & Lomb (Singapore) Pvi Ltd | 1955-04-06 | Dyskinesias; HIV Seropositivity; Immunologic Deficiency Syndromes; Hypotension, Orthostatic; Fibromyalgia; Diabetes Mellitus; T-Lymphocytopenia, Idiopathic CD4-Positive; Fatigue Syndrome, Chronic; Parkinson Disease; Glycogen Storage Disease Type II; Constipation; Poisoning; Prostatic Neoplasms, Castration-Resistant; Coronavirus Disease 2019 (COVID-19); Postural Orthostatic Tachycardia Syndrome; Lambert-Eaton Myasthenic Syndrome; Heart Failure; Myasthenia Gravis; Primary Dysautonomias; HIV Infections | Details |
Dimebolin hydrochloride | BRN-0622478; PF-01913539; DMB-I | Approved | Bigespas Ltd | Dimebon | Russian Federation | Rhinitis, Allergic; Dermatitis, Atopic; Hypersensitivity | null | 1983-01-01 | Liver Failure; Huntington Disease; Rhinitis, Allergic; Alzheimer Disease; Dementia; Dermatitis, Atopic; Hypersensitivity | Details |
Donepezil Hydrochloride | DKF-310; BNAG; E-2020; E-2022; (±)-E-2020; IVL-3003; GB-5001; HZ007 | Approved | Eisai Co Ltd | Memac, Eranz, Memorit, Aricept Evess, Aricept, Aricept ODT, Aricept D, 安理申, ADLARITY | United States | Alzheimer Disease | Eisai Inc | 1996-11-25 | Cognitive Dysfunction; Autistic Disorder; Aphasia; Central Nervous System Neoplasms; Multiple Sclerosis; Breast Neoplasms; Fragile X Syndrome; Brain Neoplasms; Psychology; Alzheimer Disease; Alcoholism; Hearing Loss, Sensorineural; Dementia; Parkinson Disease; Lewy Body Disease; Wounds and Injuries; Memory Disorders; Dementia, Vascular; Neoplasm Metastasis; Cognition Disorders; Subarachnoid Hemorrhage; Autism Spectrum Disorder; Supranuclear Palsy, Progressive; Drug-Related Side Effects and Adverse Reactions; Migraine Disorders; Brain Ischemia; Diabetes Mellitus, Type 2; Depression; Down Syndrome; Osteoporosis; Neurologic Manifestations; Visual Perception; Neoplasms; Attention Deficit Disorder with Hyperactivity; Smoking Cessation; Delirium; Anxiety Disorders; Sleep Wake Disorders; Fatigue; Stroke; Radiation Injuries | Details |
Memantine Hydrochloride/Donepezil Hydrochloride | ADS-8704; D-797/D-324; CKD 355; BPS-034; BPDO-1603; MDX-8704 | Approved | Allergan Plc | Arimenda, Namzaric | United States | Alzheimer Disease | Abbvie Inc | 2014-12-23 | Alzheimer Disease | Details |
Huperzine A | SPN-817 | Approved | Chinese Academy Of Sciences, Mayo Clinic | 哈伯因, 双益平 | Mainland China | Alzheimer Disease | Henan Taloph Pharmaceutical Stock Co Ltd | 1994-01-01 | Schizophrenia; Brain Injuries, Traumatic; Seizures; Alzheimer Disease; Epilepsy; Learning Disabilities; Memory Disorders | Details |
Distigmine Bromide | BC-51 | Approved | Torii Pharmaceutical Co Ltd | Ubretid | Japan | Glaucoma; Cystitis; Myasthenia Gravis; Strabismus | Torii Pharmaceutical Co Ltd | 1967-09-05 | Myasthenia Gravis; Cystitis; Glaucoma; Strabismus | Details |
Pralidoxime Chloride | 2-PAM-chloride | Approved | Baxter International Inc | Protopam chloride | United States | Poisoning | Baxter Healthcare Corp | 1964-03-11 | Poisoning | Details |
Pralidoxime Iodide | 2-PAMI; NSC-7760; 2-PAM Iodide | Approved | Japan | Poisoning | Sumitomo Dainippon | 1958-05-01 | Poisoning | Details | ||
Eserine Salicylate | Approved | Synapton SR, Xalieve, Antilirium | Insulin Resistance; Pain, Postoperative; Psychotic Disorders; Glaucoma | Details | ||||||
Neostigmine methylsulfate | Approved | Bloxiverz, Intrastigmina, Juvastigmin, Stiglyn, Metastigmin | Japan | Myasthenia Gravis; Muscle Hypotonia | kyowayakuhin Co | 1936-10-01 | Myasthenia Gravis; Flatulence; Urinary Retention; Reversal of Neuromuscular Blockade; Muscle Hypotonia | Details | ||
Naphazoline Hydrochloride/Neostigmine methylsulfate/Glycyrrhizinate dipotassium/Chlorphenamine Maleate/Aspartic Acid/Vitamin B6 | Approved | 新乐敦 | Details | |||||||
Dextrose/Sodium Chloride/Potassium Chloride/Floxacillin sodium | Approved | Details | ||||||||
Dextrose/Sodium Chloride/Potassium Chloride/Anthralin | Approved | Details | ||||||||
Dextrose/Sodium Chloride/Potassium Chloride/Pralidoxime Chloride | Approved | Details | ||||||||
Pralidoxime Chloride/Benactyzine Hydrochloride/Atropine Sulfate | Approved | Poisoning | Details | |||||||
Naphazoline Hydrochloride/Neostigmine methylsulfate | Approved | Details | ||||||||
Dihydrogalanthamine Hydrobromide | Approved | Mainland China | Hemiplegia; Sciatica | null | 1982-01-01 | Hemiplegia; Sciatica | Details | |||
Securinine Nitrate | Approved | Poliomyelitis; Facial Paralysis | Details | |||||||
Rivastigmine | Approved | Novartis Pharma Ag | Parkinson Disease; Alzheimer Disease | Details | ||||||
Glycopyrronium bromide/Neostigmine metilsulfate | Approved | Sintetica Gmbh | Novistig | Sintetica Gmbh | 2020-07-29 | Drug Overdose; Reversal of Neuromuscular Blockade; Muscle Hypotonia; Neuromuscular Diseases | Details | |||
Atropine/Pralidoxime Chloride | Approved | Meridian Medical Technologies Inc | DUODOTE | United States | Poisoning; Organophosphate Poisoning | Meridian Medical Technologies LLC | 2002-01-17 | Drug-Related Side Effects and Adverse Reactions; Organophosphate Poisoning; Poisoning; Drug intoxications | Details | |
Acotiamide Hydrochloride Hydrate | Z-338; YM-443 | Approved | Zeria | Acofide | Japan | Dyspepsia | null | 2013-03-25 | Dyspepsia; Nausea | Details |
Name | Research Code | Research Phase | Company | Indications | Clinical Trials |
---|---|---|---|---|---|
Octahydroaminoacridine succinate | 华洋-001 | Phase 3 Clinical | Changchun Huayang High-Tech Co Ltd, Jiangsu Sheneryang High-Tech Co Ltd | Alzheimer Disease | Details |
Donepezil/Solifenacin | CPC-201 | Phase 3 Clinical | Cipla Inc, Allergan Plc | Urologic Diseases; Alzheimer Disease; Dementia | Details |
Botulinum toxin (CKD Bio) | CKDB-501B; CKDB-501-B; CKDB-501A; CKDB-501-A; CKDB-501 | Phase 3 Clinical | CKD Bio Corp | Nasolabial fold wrinkles; Upper and lower limb spasticity | Details |
BR-4001 | BNT-002; BR-4001 | Phase 3 Clinical | Boryung Pharmaceutical Co Ltd | Alzheimer Disease | Details |
AGN-151586 | AGN-151586 | Phase 3 Clinical | Allergan Plc | Nasolabial fold wrinkles | Details |
Blarcamesine/Donepezil Hydrochloride | Phase 2 Clinical | Anavex Life Sciences Corp | Alzheimer Disease | Details | |
Ondansetron Hydrochloride/Pyridostigmine Bromide | GTB-004 | Phase 2 Clinical | Gt Biopharma Inc | Myasthenia Gravis | Details |
Pregnenolone | NBI-113 | Phase 2 Clinical | Neurocrine Biosciences Inc | Depression; Anxiety; Schizophrenia; Autism Spectrum Disorder; Menopausal symptoms; Depressive Disorder, Major; Autistic Disorder; Alcoholism; Stress Disorders, Post-Traumatic; Cocaine-Related Disorders; Low Back Pain | Details |
Fluoropezil | DC-20; DC-511020 | Phase 2 Clinical | Jiangsu Kanion Pharmaceutical Co Ltd, Shanghai Institute Of Materia Medica, Chinese Academy Of Sciences | Alzheimer Disease | Details |
Pyridostigmine | K-127 | Phase 2 Clinical | Kashiv BioSciences LLC | Musculoskeletal Diseases; Blepharoptosis; Urination Disorders; Fatigue Syndrome, Chronic | Details |
Huperizine-A (Biscayne Pharmaceuticals) | INS-001; BIS-001-ER; XEL-001-HG; XEL-001-HP; Hup-A; BIS-001 | Phase 2 Clinical | Harvard University | Seizures; Epilepsy, Complex Partial | Details |
EX-039 | EX-039 | Phase 2 Clinical | Excelsior Corp | Alzheimer Disease | Details |
donepezil (Vyant Bio) | VYNT-0126 | Phase 2 Clinical | Vyant Bio Inc | Rett Syndrome | Details |
YIV-906 | PHY-906; KD-018 | Phase 2 Clinical | Phytoceutica Inc | Liver Neoplasms; Rectal Neoplasms; Pancreatic Neoplasms; Diarrhea; Hepatitis B; Colorectal Neoplasms; Carcinoma, Hepatocellular | Details |
Benzgalantamine | GLN-1062; ALPHA-1062; ALPHA-1062IN | Phase 2 Clinical | Galantos Pharma GmbH | Brain Injuries, Traumatic; Alzheimer Disease | Details |
AD-35 | AD-35 | Phase 2 Clinical | Zhejiang Hisun Pharmaceutical Co Ltd | Alzheimer Disease | Details |
Edrophonium Chloride | Phase 1 Clinical | Teligent | Myasthenia Gravis | Details | |
18F-flubatine | 18F-flubatine; norchloro-fluoroepibatidine-[18F]; flubatine-[18F]; Fluorine-18-flubatine | Phase 1 Clinical | Helmholtz-Zentrum Dresden-Rossendorf | Alzheimer Disease | Details |
Donepezil Hydrochloride/Mefloquine Hydrochloride | THN-201 | Phase 1 Clinical | Theranexus | Cognitive Dysfunction; Alzheimer Disease | Details |
Mecripyrine Hydrochloride | SCR-1693; Y-1A; Y-1 | Phase 1 Clinical | Jiangsu Simcere Pharmaceutical Co Ltd, Yantai Yene Pharma Co Ltd, NeuroDawn Pharmaceutical Co Ltd | Brain Neoplasms; Alzheimer Disease | Details |
Methanesulfonyl fluoride | SNX-001 | Phase 1 Clinical | Senexta | Alzheimer Disease | Details |
Galantamine/Metformin | RJx-01 | Phase 1 Clinical | Rejuvenate Biomed NV | Muscular Atrophy | Details |
Donepezil transdermal patch(Dong-A ST) | DA-5207 | Phase 1 Clinical | Dong-A ST Co Ltd | Details | |
HHT-201 | HHT-201 | Phase 1 Clinical | Zhejiang Huahai Pharmaceutical Co Ltd | Hypertension; Alzheimer Disease | Details |
Octahydroaminoacridine succinate | 华洋-001 | Phase 3 Clinical | Changchun Huayang High-Tech Co Ltd, Jiangsu Sheneryang High-Tech Co Ltd | Alzheimer Disease | Details |
Donepezil/Solifenacin | CPC-201 | Phase 3 Clinical | Cipla Inc, Allergan Plc | Urologic Diseases; Alzheimer Disease; Dementia | Details |
Botulinum toxin (CKD Bio) | CKDB-501B; CKDB-501-B; CKDB-501A; CKDB-501-A; CKDB-501 | Phase 3 Clinical | CKD Bio Corp | Nasolabial fold wrinkles; Upper and lower limb spasticity | Details |
BR-4001 | BNT-002; BR-4001 | Phase 3 Clinical | Boryung Pharmaceutical Co Ltd | Alzheimer Disease | Details |
AGN-151586 | AGN-151586 | Phase 3 Clinical | Allergan Plc | Nasolabial fold wrinkles | Details |
Blarcamesine/Donepezil Hydrochloride | Phase 2 Clinical | Anavex Life Sciences Corp | Alzheimer Disease | Details | |
Ondansetron Hydrochloride/Pyridostigmine Bromide | GTB-004 | Phase 2 Clinical | Gt Biopharma Inc | Myasthenia Gravis | Details |
Pregnenolone | NBI-113 | Phase 2 Clinical | Neurocrine Biosciences Inc | Depression; Anxiety; Schizophrenia; Autism Spectrum Disorder; Menopausal symptoms; Depressive Disorder, Major; Autistic Disorder; Alcoholism; Stress Disorders, Post-Traumatic; Cocaine-Related Disorders; Low Back Pain | Details |
Fluoropezil | DC-20; DC-511020 | Phase 2 Clinical | Jiangsu Kanion Pharmaceutical Co Ltd, Shanghai Institute Of Materia Medica, Chinese Academy Of Sciences | Alzheimer Disease | Details |
Pyridostigmine | K-127 | Phase 2 Clinical | Kashiv BioSciences LLC | Musculoskeletal Diseases; Blepharoptosis; Urination Disorders; Fatigue Syndrome, Chronic | Details |
Huperizine-A (Biscayne Pharmaceuticals) | INS-001; BIS-001-ER; XEL-001-HG; XEL-001-HP; Hup-A; BIS-001 | Phase 2 Clinical | Harvard University | Seizures; Epilepsy, Complex Partial | Details |
EX-039 | EX-039 | Phase 2 Clinical | Excelsior Corp | Alzheimer Disease | Details |
donepezil (Vyant Bio) | VYNT-0126 | Phase 2 Clinical | Vyant Bio Inc | Rett Syndrome | Details |
YIV-906 | PHY-906; KD-018 | Phase 2 Clinical | Phytoceutica Inc | Liver Neoplasms; Rectal Neoplasms; Pancreatic Neoplasms; Diarrhea; Hepatitis B; Colorectal Neoplasms; Carcinoma, Hepatocellular | Details |
Benzgalantamine | GLN-1062; ALPHA-1062; ALPHA-1062IN | Phase 2 Clinical | Galantos Pharma GmbH | Brain Injuries, Traumatic; Alzheimer Disease | Details |
AD-35 | AD-35 | Phase 2 Clinical | Zhejiang Hisun Pharmaceutical Co Ltd | Alzheimer Disease | Details |
Edrophonium Chloride | Phase 1 Clinical | Teligent | Myasthenia Gravis | Details | |
18F-flubatine | 18F-flubatine; norchloro-fluoroepibatidine-[18F]; flubatine-[18F]; Fluorine-18-flubatine | Phase 1 Clinical | Helmholtz-Zentrum Dresden-Rossendorf | Alzheimer Disease | Details |
Donepezil Hydrochloride/Mefloquine Hydrochloride | THN-201 | Phase 1 Clinical | Theranexus | Cognitive Dysfunction; Alzheimer Disease | Details |
Mecripyrine Hydrochloride | SCR-1693; Y-1A; Y-1 | Phase 1 Clinical | Jiangsu Simcere Pharmaceutical Co Ltd, Yantai Yene Pharma Co Ltd, NeuroDawn Pharmaceutical Co Ltd | Brain Neoplasms; Alzheimer Disease | Details |
Methanesulfonyl fluoride | SNX-001 | Phase 1 Clinical | Senexta | Alzheimer Disease | Details |
Galantamine/Metformin | RJx-01 | Phase 1 Clinical | Rejuvenate Biomed NV | Muscular Atrophy | Details |
Donepezil transdermal patch(Dong-A ST) | DA-5207 | Phase 1 Clinical | Dong-A ST Co Ltd | Details | |
HHT-201 | HHT-201 | Phase 1 Clinical | Zhejiang Huahai Pharmaceutical Co Ltd | Hypertension; Alzheimer Disease | Details |
This web search service is supported by Google Inc.